logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12083222 B1

PDFFull Text
Date of Patent:
Sep. 10, 2024

Filed:

Aug. 16, 2019

Chemotherapeutic pharmaceutical suspension for oral dosage

Applicant:

Oncosol Limited, Harrow Middlesex, GB;

Inventors:

Sandip Mehta, Ahmedabad, IN;

Manish Kumar Umrethia, Ahmedabad, IN;

Jayanta Mandal, Ahmedabad, IN;

Assignee:

ONCOSOL LIMITED, Harrow Middlesex, GB;

Attorneys:

Merchant & Gould P.C.

Daniel R. Evans

Daniel J. Pereira

Primary Examiner:

Robert A Wax

Assistant Examiner:

Quanglong N Truong

Int. Cl.
CPC ...
A61K 9/10 (2006.01); A61K 31/404 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01);
U.S. Cl.
CPC ...
A61K 9/10 (2013.01); A61K 31/404 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01);
Abstract

Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an anti-cancer active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the anti-cancer active pharmaceutical ingredient is selected from ibrutinib, nilotinib, dasatinib, sunitinib, sorafenib, erlotinib, and capecitabine.

Find Patent Forward Citations

Mehta, Sandip. (2024). Chemotherapeutic pharmaceutical suspension for oral dosage (U.S. Patent No. 12083222). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12083222

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…